The following material has been sourced from the Australian Institute of Health and Welfare
Uterine cancer incorporates ICD-10 cancer codes C54 (Malignant neoplasm of corpus uteri) and C55 (Malignant neoplasm of uterus, part unspecified).
The statistics on this page therefore incorporate endometrial cancer, uterine sarcoma and other cancers of the womb. Endometrial cancer accounts for around 90-95 per cent of uterine cancer diagnoses. Statistics for uterine sarcoma are not reported separately.
New cases
In 2021, uterine cancer was the tenth most commonly diagnosed cancer in Australia, and the fifth most commonly diagnosed cancer among females in Australia. It is estimated that it will remain the tenth most commonly diagnosed cancer in Australia and the fifth most commonly diagnosed cancer among females in Australia in 2025.
In 2021, there were 3,181 new cases of uterine cancer diagnosed in Australia. In 2025, it is estimated that 3,493 new cases of uterine cancer will be diagnosed in Australia. In 2025, it is estimated that a female has a 1 in 46 (or 2.2%) risk of being diagnosed with uterine cancer by the age of 85.
Graph: statistics-uterine-cancer-figure-1-estimated-cancer-incidence-females-2025
In 2021, the age-standardised incidence rate was 24 cases per 100,000 females. In 2025, it is estimated that the age-standardised incidence rate will be 24 cases per 100,000 females. The incidence rate for uterine cancer is expected to increase with age, up to 75–79 years.
Graph: statistics-uterine-cancer-figure-2-age-standardised-incidence-rates
The number of new cases of uterine cancer diagnosed increased from 943 in 1982 to 3,181 in 2021. Over the same period, the age-standardised incidence rate increased from 17 cases per 100,000 females in 1982 to 24 cases per 100,000 females in 2021.
Deaths
In 2021, uterine cancer was the eighth most common cause of cancer death among females in Australia. It is estimated that it will remain the eighth most common cause of death from cancer among females in Australia in 2025.
In 2023, there were 643 deaths from uterine cancer in Australia. In 2025, it is estimated that there will be 706 deaths. In 2025, it is estimated that a female has a 1 in 237 (or 0.42%) risk of dying from uterine cancer by the age of 85.
Graph: statistics-uterine-cancer-figure-3-estimated-cancer-mortality-females-2025
In 2023, the age-standardised mortality rate was 4.6 deaths per 100,000 females. In 2025, it is estimated that the age-standardised mortality rate will be 4.8 deaths per 100,000 females. The mortality rate for uterine cancer is expected to increase with age.
Graph: statistics-uterine-cancer-figure-4-age-standardised-mortality-rates
The number of deaths from uterine cancer increased from 222 in 1982 to 643 in 2023. Over the same period, the age-standardised mortality rate increased from 4.3 deaths per 100,000 females in 1982 to 4.8 deaths per 100,000 females in 2023.
Survival
In 2017–2021, individuals diagnosed with uterine cancer had an 83% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2017–2021, five-year relative survival for uterine cancer increased from 78% to 83%.
Graph: statistics-uterine-cancer-figure-5-5-year-relative-survival
Prevalence
At the end of 2021, there were 3,039 people living who had been diagnosed with uterine cancer that year, 12,716 people living who had been diagnosed with uterine cancer in the previous 5 years (from 2017 to 2021) and 39,297 people living who had been diagnosed with uterine cancer in the previous 40 years (from 1982 to 2021).
For more information on cancer data, see the NCCI website
The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes. The NCCI website allows users to see visual representations of data on each indicator through interactive charts.
